Inimmune
  • About
    • Vision/Mission
    • About Us
    • Management Team
    • Board of Directors
  • Pipeline
  • Research
  • News
  • Investors
  • Careers
  • Contact
Select Page
Inimmune Receives $1M SBIR Phase II Grant

Inimmune Receives $1M SBIR Phase II Grant

Oct 16, 2019 | News

Montana biotech company receives Small Business Innovation Research Grant to develop novel treatments against infectious diseases. Inimmune Corporation, a biotechnology company located in Missoula, MT, was recently awarded $1,017,317 from the National Institute for...

Recent Posts

  • UM Receives Largest Single Research Award in its History
  • Inimmune raises $22 Million in Series A Funding Led by Two Bear Capital
  • Biotech Company Announces $22 Million Investment Led by Mike Goguen’s Firm
  • Montana Biotech Company Receives $2 M Small Business Innovation Research Grant to Advance Vaccine Technologies
  • Development of COVID-19 Vaccine, Tests Advancing in Montana

Archives

  • October 2020
  • July 2020
  • June 2020
  • October 2019
  • December 2018
  • February 2018
  • July 2017
  • November 2016
  • August 2016

BACK TO NEWS

© 2020 Inimmune